|
| 36914816 | SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers. | Nat Cancer | 2023 |
| 37683456 | Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. | Biochem Biophys Res Commun | 2023 |
| 34491744 | Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors. | J Med Chem | 2021 |
| 33822623 | Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer. | J Med Chem | 2021 |
| 34408078 | The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia. | Sci Transl Med | 2021 |
| 32371575 | EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth. | Mol Cancer Ther | 2020 |
| 30806949 | Discovery of novel inhibitors of human galactokinase by virtual screening. | J Comput Aided Mol Des | 2019 |
| 32184968 | Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors. | ACS Med Chem Lett | 2019 |
| 30979745 | High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma. | Clin Cancer Res | 2019 |
| 29555419 | Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors. | Bioorg Med Chem | 2018 |
| 30648156 | Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space. | ACS Cent Sci | 2018 |
| 29207616 | PKM2 activation sensitizes cancer cells to growth inhibition by 2-deoxy-D-glucose. | Oncotarget | 2017 |
| 28986582 | Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays. | Sci Rep | 2017 |
| 29141225 | A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. | Cell Rep | 2017 |
| 27552339 | Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. | ACS Chem Biol | 2016 |
| 27110680 | A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. | Nat Chem Biol | 2016 |
| 27434767 | Corrigendum: A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. | Nat Chem Biol | 2016 |
| 26838815 | Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. | Nat Commun | 2016 |
| 27428418 | A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics. | EBioMedicine | 2016 |
| 27238019 | Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery. | Cell | 2016 |
| 27482083 | Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein. | Proc Natl Acad Sci U S A | 2016 |
| 27458230 | Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic Activity. | Antimicrob Agents Chemother | 2016 |
| 27804975 | Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. | Nat Commun | 2016 |
| 27681596 | Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models. | J Biol Chem | 2016 |
| 26481663 | PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth. | Mol Cell | 2015 |
| 25553891 | Structure activity relationships of human galactokinase inhibitors. | Bioorg Med Chem Lett | 2015 |
| 25653139 | Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. | Nat Commun | 2015 |
| 25896324 | Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. | Nature | 2015 |
| 25940539 | Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. | Oncotarget | 2015 |
| 25068984 | GALK inhibitors for classic galactosemia. | Future Medicinal Chemistry | 2014 |
| 24418991 | Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein. | Leukemia | 2014 |
| 24469833 | High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. | Proc Natl Acad Sci U S A | 2014 |
| 24668804 | Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1. | J Biol Chem | 2014 |
| 24699711 | A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. | Nat Commun | 2014 |
| 24900769 | Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase. | ACS Med Chem Lett | 2013 |
| 23850693 | Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors. | Biochem Biophys Res Commun | 2013 |
| 23273517 | Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors. | Bioorg Med Chem Lett | 2013 |
| 23326584 | A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation. | PLoS One | 2013 |
| 22906073 | A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase. | Biochem J | 2012 |
| 22922757 | Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. | Nat Chem Biol | 2012 |
| 21958545 | 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. | Bioorg Med Chem Lett | 2011 |
| 21291394 | Chiral kinase inhibitors. | Curr Top Med Chem | 2011 |
| 22052977 | Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. | Science | 2011 |
| 21721528 | Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein. | J Med Chem | 2011 |
| 20229566 | A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. | ChemMedChem | 2010 |
| 21516235 | Total synthesis of LL-Z1640-2 utilizing a late-stage intramolecular Nozaki-Hiyama-Kishi reaction. | Tetrahedron Lett | 2010 |
| 20451379 | Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. | Bioorg Med Chem Lett | 2010 |
| 20017496 | Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. | J Med Chem | 2010 |
| 18181637 | Super silyl group for a sequential diastereoselective aldol-polyhalomethyllithium addition reaction. | Organic Letters | 2008 |
| 18193878 | Ketone super silyl enol ethers in sequential reactions: diastereoselective generation of tertiary carbinols in one pot. | Journal of the American Chemical Society | 2008 |